Clinical Trial Update: Glimepiride, Empagliflozin, and Sitagliptin With Metformin for Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial update showing completion of a study evaluating a fixed-dose combination of glimepiride, empagliflozin, sitagliptin, and metformin for Type 2 Diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• Glimepiride (glimepiride)
• Sitagliptin (sitagliptin)
• metformin (metformin)

Snippet

Sponsor: Bahria University | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED